0001104659-22-117992.txt : 20221114
0001104659-22-117992.hdr.sgml : 20221114
20221114092816
ACCESSION NUMBER: 0001104659-22-117992
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20220930
FILED AS OF DATE: 20221114
DATE AS OF CHANGE: 20221114
EFFECTIVENESS DATE: 20221114
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Foresite Capital Management IV, LLC
CENTRAL INDEX KEY: 0001704132
IRS NUMBER: 821204449
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-18415
FILM NUMBER: 221381173
BUSINESS ADDRESS:
STREET 1: 900 LARKSPUR LANDING CIRCLE, SUITE 150
CITY: LARKSPUR
STATE: CA
ZIP: 94939
BUSINESS PHONE: 415-877-4887
MAIL ADDRESS:
STREET 1: 900 LARKSPUR LANDING CIRCLE, SUITE 150
CITY: LARKSPUR
STATE: CA
ZIP: 94939
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
false
false
0001704132
XXXXXXXX
09-30-2022
09-30-2022
false
Foresite Capital Management IV, LLC
900 Larkspur Landing Circle, Suite 150
Larkspur
CA
94939
13F HOLDINGS REPORT
028-18415
N
James B. Tananbaum
Managing Member
415-877-4887
/s/ James B. Tananbaum
San Francisco
CA
11-10-2022
0
8
310955
INFORMATION TABLE
2
infotable.xml
Aclaris Therapeutics, Inc.
COM
00461U105
44198
2808034
SH
SOLE
2808034
0
0
Cymabay Therapeutics, Inc.
COM
23257D103
6255
1787094
SH
SOLE
1787094
0
0
Kinnate Biopharma Inc.
COM
49705R105
115576
9671643
SH
SOLE
9671643
0
0
Kura Oncology, Inc.
COM
50127T109
25270
1849947
SH
SOLE
1849947
0
0
Lyell Immunopharma, Inc.
COM
55083R104
73300
10000000
SH
SOLE
10000000
0
0
Pharvaris N.V.
COM
N69605108
24904
3246926
SH
SOLE
3246926
0
0
Quantum-Si Incorporated
COM CL A
74765K105
4871
1771249
SH
SOLE
1771249
0
0
Syndax Pharmaceuticals, Inc.
COM
87164F105
16581
690000
SH
SOLE
690000
0
0